The E-nside, multi-inner branch-based off-the-shelf stent graft for the treatment of thoracoabdominal aortic aneurysms.

IF 2.7 Expert review of medical devices Pub Date : 2025-03-01 Epub Date: 2025-02-24 DOI:10.1080/17434440.2025.2465686
Paolo Calo, Miroslav Yordanov, Schäfers Johannes Frederik, Alexander Oberhuber
{"title":"The E-nside, multi-inner branch-based off-the-shelf stent graft for the treatment of thoracoabdominal aortic aneurysms.","authors":"Paolo Calo, Miroslav Yordanov, Schäfers Johannes Frederik, Alexander Oberhuber","doi":"10.1080/17434440.2025.2465686","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Endovascular repair for thoracoabdominal aortic aneurysms (TAAAs) has changed treatment paradigm over the past decades. However for urgent cases, there are not many options available. The E-nside (Artivion, Georgia, U.S.A.) endograft is one of the three off-the-shelf-aortic endografts available on the market. Its unique design with four inner branches and other special features offer more versatility, so more patients could be minimally invasively treated.</p><p><strong>Areas covered: </strong>We present a descriptive review based on market analysis on the available devices and a PubMed literature research on the E-nside endograft. The aim of this article is to present its unique structure, deployment method, and cannulation methods and discuss its applicability, indications, associated concerns and an overview of the available alternative devices.</p><p><strong>Expert opinion: </strong>The implantation of the E-nside endograft is a promising technique for treating not only TAAAs but also complex abdominal aortic aneurysm. Unlike FEVAR or BEVAR, which require precise planning and have the disadvantage of long manufacturing time. We think that with the off-the-shelf feature from E-nside endograft this can be obviated, and through its flexible planning along with its simple use, more patients could benefit and so favorable results can be achieve.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"177-185"},"PeriodicalIF":2.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert review of medical devices","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17434440.2025.2465686","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/24 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Endovascular repair for thoracoabdominal aortic aneurysms (TAAAs) has changed treatment paradigm over the past decades. However for urgent cases, there are not many options available. The E-nside (Artivion, Georgia, U.S.A.) endograft is one of the three off-the-shelf-aortic endografts available on the market. Its unique design with four inner branches and other special features offer more versatility, so more patients could be minimally invasively treated.

Areas covered: We present a descriptive review based on market analysis on the available devices and a PubMed literature research on the E-nside endograft. The aim of this article is to present its unique structure, deployment method, and cannulation methods and discuss its applicability, indications, associated concerns and an overview of the available alternative devices.

Expert opinion: The implantation of the E-nside endograft is a promising technique for treating not only TAAAs but also complex abdominal aortic aneurysm. Unlike FEVAR or BEVAR, which require precise planning and have the disadvantage of long manufacturing time. We think that with the off-the-shelf feature from E-nside endograft this can be obviated, and through its flexible planning along with its simple use, more patients could benefit and so favorable results can be achieve.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
e- inside多内支支架用于胸腹主动脉瘤的治疗。
在过去的几十年中,胸腹主动脉瘤(TAAAs)的血管内修复已经改变了治疗模式。然而,对于紧急情况,可用的选择并不多。E-nside (Artivion, Georgia, usa)是市场上三种现成的主动脉内移植物之一。其独特的设计,四个内部分支和其他特殊功能提供了更多的多功能性,因此更多的病人可以进行微创治疗。涵盖的领域:我们提出了一个描述性的回顾,基于市场分析的可用设备和已发表的文献研究的e -内腔移植物。本文的目的是介绍其独特的结构,部署方法,插管方法,并讨论其适用性,适应症,相关问题和可用替代设备的概述。专家意见:内腔内移植物的植入是一种很有前途的技术,不仅治疗TAAAs,而且治疗复杂的腹主动脉瘤。不像FEVAR或BEVAR需要精确的计划,缺点是制造时间长。我们认为e- nsideendograft的现成特性可以避免这种情况,并且通过其灵活的计划和简单的使用,可以使更多的患者受益,从而达到良好的效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The impact of integrating artificial intelligence into regulatory affairs functions in the Medtech industry. Medical device errors in intensive care units and patient safety: a systematic review. How can we improve public understanding and use of automated external defibrillators? Investigation of consistency in sleep quality evaluation using a Fitbit device compared to a structured questionnaire among breastfeeding mothers in Ho Chi Minh City, Vietnam. The current status and future of using computational models to individually optimise cochlear implant stimulation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1